| ALDH1A3 loss of function causes bilateral anophthalmia/microphthalmia and hypoplasia of the optic nerve and optic chiasm M Yahyavi, H Abouzeid, G Gawdat, AS De Preux, T Xiao, T Bardakjian, ... Human molecular genetics 22 (16), 3250-3258, 2013 | 82 | 2013 |
| Ketamine treatment for depression: a review M Yavi, H Lee, ID Henter, LT Park, CA Zarate Jr Discover mental health 2 (1), 9, 2022 | 74 | 2022 |
| VAX1 mutation associated with microphthalmia, corpus callosum agenesis, and orofacial clefting: The first description of a VAX1 phenotype in humans AM Slavotinek, R Chao, T Vacik, M Yahyavi, H Abouzeid, T Bardakjian, ... Human mutation 33 (2), 364-368, 2012 | 72 | 2012 |
| Manitoba-oculo-tricho-anal (MOTA) syndrome is caused by mutations in FREM1 AM Slavotinek, SE Baranzini, D Schanze, C Labelle-Dumais, KM Short, ... Journal of medical genetics 48 (6), 375-382, 2011 | 70 | 2011 |
| Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1 AM Slavotinek, P Mehrotra, I Nazarenko, PLF Tang, R Lao, D Cameron, ... Human Molecular Genetics 22 (4), 696-703, 2013 | 41 | 2013 |
| Targeted 'Next-Generation' sequencing in anophthalmia and microphthalmia patients confirms SOX2, OTX2 and FOXE3 mutations N Lopez Jimenez, J Flannick, M Yahyavi, J Li, T Bardakjian, L Tonkin, ... BMC Medical Genetics 12, 1-8, 2011 | 25 | 2011 |
| Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration R Moaddel, P Zanos, CA Farmer, B Kadriu, PJ Morris, J Lovett, ... Translational Psychiatry 12 (1), 179, 2022 | 13 | 2022 |
| Sex chromosome dosage effects on white matter structure in the human brain A Warling, M Yavi, LS Clasen, JD Blumenthal, FM Lalonde, A Raznahan, ... Cerebral Cortex 31 (12), 5339-5353, 2021 | 7 | 2021 |
| Key considerations in the pharmacological management of treatment-resistant depression M Yavi, ID Henter, LT Park, C Zarate Expert opinion on pharmacotherapy 22 (17), 2405-2415, 2021 | 6 | 2021 |
| Exome-wide association study of treatment-resistant depression suggests novel treatment targets SB Shah, TN Peddada, C Song, M Mensah, H Sung, M Yavi, P Yuan, ... Scientific Reports 13 (1), 12467, 2023 | 2 | 2023 |
| Long-term follow-up of participants in ketamine clinical trials for mood disorders KT Hurst, A Vogeley, DK Greenstein, L Durland, S Makel, PR Wang, ... Journal of Affective Disorders 357, 134-137, 2024 | 1 | 2024 |
| The effect of music on response to ketamine: A scoping review protocol M Kheirkhah, AC Nugent, AA Livinski, L Neely, SC Johnson, ... OSF, 2023 | 1 | 2023 |
| An Open-Label Study of Adjunctive Dextromethorphan/Quinidine in Treatment-Resistant Depression PR Wang, M Yavi, H Lee, Y Kotb, L Shora, LT Park, CA Zarate Jr Journal of clinical psychopharmacology, 10.1097, 2022 | 1 | 2022 |
| Exploring the Impact of Music on Response to Ketamine/Esketamine: A Scoping Review M Kheirkhah, AC Nugent, AA Livinski, L Neely, SC Johnson, ID Henter, ... Neuroscience & Biobehavioral Reviews, 105693, 2024 | | 2024 |
| Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion R Moaddel, CA Farmer, M Yavi, B Kadriu, M Zhu, J Fan, Q Chen, ... iScience 26 (12), 2023 | | 2023 |
| Magnetoencephalography Changes During a WorkingMemory Task in Treatment-Resistant Depression Patients Following a Subanesthetic Dose of Intravenous Ketamine A Fijtman, M Yavi, A Vogeley, D Greenstein, J Gilbert, C Zarate NEUROPSYCHOPHARMACOLOGY 48, 207-207, 2023 | | 2023 |
| 208. Dextromethorphan-Quinidine in Treatment-Resistant Depression: An Open-Label Pilot Study P Wang, M Yavi, L Park, C Zarate Biological Psychiatry 93 (9), S177-S178, 2023 | | 2023 |
| Baseline Differences and Treatment-Responsiveness to Reelin and (2R, 6R)-HNK of IPSC-Derived Neurons From Participants With Treatment-Resistant Depression J Johnston, B Quintanilla, P Yuan, M Yavi, H Caruncho, B Kadriu, ... NEUROPSYCHOPHARMACOLOGY 47 (SUPPL 1), 186-186, 2022 | | 2022 |
| T61. PERSONAL UTILITY OF POLYGENIC RISK SCORES: ATTITUDES AND INTEREST AMONG INDIVIDUALS WITH MAJOR DEPRESSIVE DISORDER AND TREATMENT RESISTANT DEPRESSION R Gore, M Setzer, C Jodarski, M Yavi, E Ballard, M Kamen, R Duncan, ... European Neuropsychopharmacology 63, e201-e202, 2022 | | 2022 |
| EXOME-WIDE ASSOCIATION STUDY OF TREATMENT-RESISTANT DEPRESSION SUGGESTS NOVEL TREATMENT TARGETS S Shah, T Peddada, C Song, M Mensah, H Sung, M Yavi, P Yaun, ... European Neuropsychopharmacology 63, e268, 2022 | | 2022 |
